Case Collection in RA: Highlights of an Interactive Workshop

Slides:



Advertisements
Similar presentations
CHER Trial: Early Antiretroviral Therapy and Mortality Among HIV- Infected Infants New England J Med 2008;359 (21):
Advertisements

What's New in Basal Insulin for Diabetes
Upfront Combination Therapy vs Step-Up Approach for PAH:
Applying the New Multiple Sclerosis Guidelines to Clinical Practice
Major Depressive Disorder: Latest Clinical Update
Diabetic Dyslipidemia in Practice
Nurses' Toolbox: How to Improve Patient Outcomes in Multiple Myeloma
NOACs for Cancer-Associated Thrombosis:
Optimizing Therapy for Osteoarthritis
Objective Assessment of RA: Expanding the Horizons
The Clinical Enigma of Cardiogenic Shock
Optimizing Use of Biological Agents in Ulcerative Colitis
Diagnosing Rheumatoid Arthritis Early
The Patient Journey to Remission in MDD: A Collaborative Approach
Program Goals. Implementing the Updated American Thyroid Association Guidelines and Recommendations for RAI-R DTC.
Medication Nonadherence in Gout
American Heart Association Scientific Sessions
Complicated Cases in Ulcerative Colitis
Getting the Best out of Guidelines in the Rapidly Changing Landscape of RA Treatment.
IL-17 Inhibitors in the Management of Psoriatic Disease
Decision-making in the eRA of Treating to Target
PAH Therapy Revisited.
The future of urate-lowering strategies for gout
Managing IBD.
Targeting Osteoporosis Therapies to Patients at Highest Risk for Fracture.
Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?
Program Goals. Implementing the Updated American Thyroid Association Guidelines and Recommendations for RAI-R DTC.
Examining the Latest Evidence in PAH
New LDL-C Lipid Targets
Biotherapeutics.
Debating the Issues in Rheumatoid Arthritis with the Experts: Early Treatment and Targets.
Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis.
Diagnosing Focal Epilepsy: A Clinical Case
Advancing the Treatment of IBD With Biologics
Updated Guideline Recommendations for the Definitive Diagnosis of Unexplained Syncope.
Treating to Target in MS
Multidisciplinary Management of Hyperkalemia:
Introduction. Clinical Scenario: Encouraging Adherence in Patients with Schizophrenia.
Staying Abreast of Best Practices Across the Clinical Continuum
Intro: Biomarkers in RA
What's New in Therapeutic Options for Moderate to Severe RA?
The Road to Quality Improvement in HER2-Positive Breast Cancer
When Is Intrathecal Drug Delivery Appropriate?
Optimizing Insulin Therapy in Primary Care: Basal Plus Incretin Combinations.
Optimizing Targeted Therapy for HER2-Positive Advanced Breast Cancer: Considerations for Previously Treated Disease.
New ELN Recommendations
Communicating With Your Patients About Major Depressive Disorder
Essential Updates for PsA: A Complex Disease to Manage
Improving Outcomes in Patients With SSc-ILD
Clinical Challenges and Updates in Managing Seizure Clusters
Assessing the Burden of Hyperkalemia
THE CONTINUUM OF CARE IN mCRC: OPTIMIZING USE OF EGFR ANTIBODIES
Saving the Day.
When Is Intrathecal Drug Delivery Appropriate?
Breaking Barriers in PAH: Role of Novel Early Treatment Strategies
Optimizing Outcomes for Patients With Systemic Lupus Erythematosus: Key Considerations.
Optimizing Front-Line Endocrine Therapy in Metastatic Breast Cancer
Checkpoint Inhibitors in First-Line Advanced NSCLC
Clinical Challenges in the Patient With Relapsed Multiple Myeloma
Assessing the Burden of Hyperkalemia
Championing Evidence-Based Care in Patients With Acute Low Back Pain
A Closer Look.
Introduction. Welcome to this program, titled De-Escalating Therapy in Epilepsy: A Return to Monotherapy.
Optimizing Treatment of Refractory Gout
Merging the Art and Science of Managing nOH in Clinical Practice
Treatment Advances for RA
Disease Activity Cutoffs for ACR-Recommended RA Disease Activity Measure
Patient Heterogeneity in CD
Meet the JAKs.
Women With Psoriasis Are Struggling More Than Men
Presentation transcript:

Case Collection in RA: Highlights of an Interactive Workshop

Learning Objectives

ACR/EULAR New Classification Criteria for RAa

2012 Updated ACR Recommendations for the Treatment of RA

Poor Prognostic Features

RA Therapies Included in the 2012 ACR Recommendations

Initiating Therapy for Early RA: 2012 ACR Guidelines

EULAR and International Task Force Recommendations

Treating to Target: Essential Conceptsa

Treating to Target: Essential Concepts (cont)

ACR/EULAR: 2 Definitions of Remission in RA Clinical Trials

2010 ACR/EULAR RA Classification Criteria

Screening for TB in Candidates for Biologic Therapy

Case scenarios for your consideration

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)